Increased mortality from acute liver failure in Mexico
Journal Title: Annals of Hepatology - Year 2012, Vol 11, Issue 2
Abstract
Introduction. There is significant geographic variation in the etiology and prognosis of acute liver failure (ALF). Since, little information is available for Latin America. We analyzed ALF mortality trends in Mexico. Material and methods. The rates of mortality attributable to ALF were obtained for 1998 to 2009 from the National System of Health Information in Mexico and analyzed according to date, etiology, sex, age and geographic characteristics through graphical assessment and joinpoint regression. Results. From 1998 to 2009, 2,193 ALF-related deaths were reported. A threefold increase in ALF mortality was observed during the period from 1998 to 2009 (the global mortality rate increased from 13.1 to 40.2 deaths per 10,000,000 inhabitants). The most significant increase was observed for viral etiologies after 2006, affecting people 45 years old and over. Conclusion. ALF-related deaths have increased since 2006. Although we cannot speculate on the specific causes of this increase, it may reflect improvements in the access of vulnerable populations to health care.
Authors and Affiliations
Norberto Chávez-Tapia, Tonatiuh Barrientos-Gutiérrez, Carlos Guerrero-López
Keywords
Related Articles
- EP ID EP78130
- DOI -
- Views 111
- Downloads 0
PTEN at the crossroad of metabolic diseases and cancer in the liver
The tumor suppressor PTEN is a phosphoinositide phosphatase regulating the PI3K/Akt signaling pathways and mutated or deleted in a variety of human cancers. Recent evidence indicates that dysregulated PTEN expression and...
Bile salt export pump deficiency disease: two novel, late onset, ABCB11 mutations identified by next generation sequencing
Progressive familial intrahepatic cholestasis (PFIC) is a heterogeneous group of autosomal recessive cholestatic diseases of childhood and represents the main indication for liver transplantation at this age; PFIC2 invo...
Prevalence of non-alcoholic fatty liver disease: population based study
Background and aim: Non-alcoholic fatty liver disease (NAFLD) is a common cause of chronic liver disease and liver transplantation in western countries. Increasing incidence of NAFLD has been well documented from Asian c...
Elafibranor for the treatment of NAFLD: One pill, two molecular targets and multiple effects in a complex phenotype.
Primary care practitioners survey of non-alcoholic fatty liver disease
Background. The rising incidence of non alcoholic fatty liver disease (NAFLD) mirrors the epidemics of obesity and metabolic syndrome. Primary care practitioners (PCPs) are central to management of patients with NAFLD, b...